NYSEARCA:PSIL AdvisorShares Psychedelics ETF (PSIL) Price, Holdings, & News $24.86 -0.01 (-0.04%) As of 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatings About AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PSIL alerts:Sign Up Key Stats Today's Range$24.70▼$25.0550-Day Range$23.14▼$26.8052-Week Range$15.63▼$27.02Volume26,086 shsAverage Volume34,322 shsMarket Capitalization$51.71 millionAssets Under Management$57.25 millionDividend Yield6.84%Net Expense Ratio0.99%Aggregate RatingModerate Buy ETF Overview The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares. Read More AdvisorShares Psychedelics ETF ExpensesTypePSILTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.60%0.57%0.57%0.50%0.53%Other Expenses1.24%0.57%0.53%0.60%0.54%Total Expense1.84%0.72%0.75%0.75%0.73%Fee Waiver-0.85%-0.72%-0.67%-0.78%-0.68%Net Expense0.99%0.60%0.63%0.57%0.60% Receive PSIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PSIL ETF News Headlines(PSIL) AdvisorShares Psychedelics ETFSeptember 1, 2026 | sa.investing.comDrilldown: AdvisorShares psychedelics ETFMay 28, 2026 | msn.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.September 21 at 1:00 AM | Weiss Ratings (Ad)Trump Pushes for Speedy Psychedelic Approvals, Sending Stocks SurgingApril 20, 2026 | wsj.comPsychedelic stocks soar as Trump signs order to ease accessApril 20, 2026 | msn.comSave this psychedelic stock watchlist after Trump’s latest executive orderApril 20, 2026 | msn.comSee More Headlines PSIL ETF - Frequently Asked Questions How have PSIL shares performed this year? AdvisorShares Psychedelics ETF's stock was trading at $17.17 on January 1st, 2026. Since then, PSIL stock has increased by 44.5% and is now trading at $24.81. Who are AdvisorShares Psychedelics ETF's major shareholders? AdvisorShares Psychedelics ETF's top institutional investors include Vigilare Wealth Management (0.47%). How do I buy shares of AdvisorShares Psychedelics ETF? Shares of PSIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of AdvisorShares Psychedelics ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that AdvisorShares Psychedelics ETF investors own include Tilray Brands (TLRY), Bright Minds Biosciences (DRUG), Las Vegas Sands (LVS), NVIDIA (NVDA), Archer Aviation (ACHR), Blink Charging (BLNK). Fund Details IssuerAdvisorShares Fund NameAdvisorShares Psychedelics ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PSIL Inception Date9/15/2021 Fund ManagerDan S. Ahrens WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings35 Fund Statistics Assets Under Management$57.25 million Average Daily Volume$0.00 Discount/Premium0.19% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorAdvisorShares Investments, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume32 Put Options0 Call Options32 Miscellaneous Outstanding Shares2,080,000Beta0.96 Creation Fee$500.00 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report Top 10 PSIL HoldingsCompass Pathways (NASDAQ:CMPS)Holding Weight: 12.28%Definium Therapeutics (NASDAQ:DFTX)Holding Weight: 10.58%Cybin Inc.Holding Weight: 9.12%Blackrock Treasury Trust Instl 62Holding Weight: 7.89%Neuronetics (NASDAQ:STIM)Holding Weight: 4.91%NRx Pharmaceuticals (NASDAQ:NRXP)Holding Weight: 4.68%GH Research (NASDAQ:GHRS)Holding Weight: 4.58%Neurocrine Biosciences (NASDAQ:NBIX)Holding Weight: 4.46%Relmada Therapeutics (NASDAQ:RLMD)Holding Weight: 4.46%AbbVie (NYSE:ABBV)Holding Weight: 4.30%Full Holdings DetailsPSIL Sector ExposurePSIL Industry Exposure This page (NYSEARCA:PSIL) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PSIL Stock Alerts